Search

everythinglearnresearchcommunity

for

Search:↓

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

Prostate surgery is often effective long-term, but some patients may need more treatment or another surgery, especially if they had prostatitis before.

Ginseng was more effective than finasteride in treating enlarged prostate in rats.

People with hair loss may have worse urinary symptoms due to an enlarged prostate.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

CEC levels may be a useful marker for predicting prostate cancer progression.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

Men with enlarged prostates often have more severe baldness.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.